Table 4 General characteristics of the patients with renal insufficiency at the beginning and in the course of treatment
Patient number | Age & gender | Time of RI | Type of RI | BUN, creatinine at the beginning of treatment | BUN, creatinine at the end of treatment | Concomitants nephrotoxic agent use | Type and duration of RRT | Duration of treatment | Outcome |
|---|---|---|---|---|---|---|---|---|---|
P4 | 11/M | Before treatment | Oliguric ARF | 36/1.3 | 23/1.6 | Amphotericin B | One day of hemodialysis | 19 | Survey |
P8 | 7/M | During the treatment | Oliguric ARF | 8/0.2 | 53/5.6 | Aminoglycoside, glycopeptides | 14 days of peritoneal dialysis | 22 | Survey |
P12 | 2.5/F | During the treatment | Non-oliguric ARF | 7/0.2 | 20/1.6 | Aminoglycoside | Colistin treatment was halted | 8 | Survey |
RRT was not performed | |||||||||
P15 | 12/F | During the treatment | Non-oliguric ARF | 7/0.2 | 89/3.2 | Glycopeptides, amphotericin B | RRT was not performed | 8 | Death* |
P26 | 17/M | Before treatment | CRF | 66/2.5 | 111/2.5 | Non | 8 days of hemodialysis | 10 | Death* |
P38 | 7/M | Before treatment | ARF | 76/2.3 | 38/1.2 | Glycopeptides | 4 days of peritoneal dialysis | 4 | Death** |